FDA Proposes Draft Guidance to Ensure AI Credibility in Drug and Biologic SubmissionsMarketing ELS2025-01-14T16:21:37+00:0014 de January, 2025|
Anvisa Updates Procedures for Borderline ProductsMarketing ELS2025-01-07T10:54:44+00:007 de January, 2025|
